Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

BUY
$46.5 - $79.14 $2.26 Million - $3.85 Million
48,703 New
48,703 $2.3 Million
Q2 2022

Aug 15, 2022

BUY
$63.06 - $84.75 $501,074 - $673,423
7,946 Added 11.53%
76,855 $5.51 Million
Q1 2022

May 13, 2022

SELL
$74.15 - $99.36 $926,875 - $1.24 Million
-12,500 Reduced 15.35%
68,909 $5.58 Million
Q4 2021

Feb 14, 2022

BUY
$86.01 - $102.89 $200,919 - $240,351
2,336 Added 2.95%
81,409 $8.36 Million
Q3 2021

Nov 03, 2021

BUY
$84.7 - $96.31 $39,385 - $44,784
465 Added 0.59%
79,073 $6.92 Million
Q2 2021

Aug 12, 2021

BUY
$76.44 - $89.57 $3.72 Million - $4.36 Million
48,650 Added 162.39%
78,608 $7.03 Million
Q1 2021

May 13, 2021

SELL
$67.36 - $80.76 $559,155 - $670,388
-8,301 Reduced 21.7%
29,958 $2.27 Million
Q4 2020

Feb 12, 2021

BUY
$53.08 - $69.86 $2.03 Million - $2.67 Million
38,259 New
38,259 $2.61 Million

Others Institutions Holding SYNH

About Syneos Health, Inc.


  • Ticker SYNH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 102,653,000
  • Description
  • Syneos Health, Inc. provides biopharmaceutical outsourcing solutions company in North America, Europe, the Middle East, Africa, the Asia-Pacific, and Latin America. It operates through two segments, Clinical Solutions and Commercial Solutions. The Clinical Solutions segment offers services for the development of diagnostics, drugs, biologics, de...
More about SYNH
Track This Portfolio

Track Segall Bryant & Hamill, LLC Portfolio

Follow Segall Bryant & Hamill, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Segall Bryant & Hamill, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Segall Bryant & Hamill, LLC with notifications on news.